RSH 4.76% 4.0¢ respiri limited

Ann: wheezo Registered and Approved for Sale in the UK Market, page-9

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 120 Posts.
    lightbulb Created with Sketch. 47
    You need to read the announcement carefully, wheezo had already received UK market approval via the CE mark process previously which covered the EU - that event was price sensitive. This is now the new UK specific approval which replaces CE mark since it left the EU and comes into effect from 2022. The positive is further confirmation that wheezo is a fit for purpose device for remote monitoring of asthma management by one of the most demanding regulatory authorities in the world, can be sold in the UK and RSH's plans are on track for launch in Q4 / 2021 in a market 10 times bigger than Australia.
 
watchlist Created with Sketch. Add RSH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.